Europe Biosimilar Insulin Glargine & Lispro Market - Forecast & Opportunities, 2024

End User (Type 1 Diabetes and Type 2 Diabetes),By Country (Germany, United Kingdom, France, Italy, Spain, Russia, Turkey, Poland, The Netherlands, Austria & Rest of Europe) By Competition,

Published	Pages	Publisher	Report code
Jan 2020	86	TechSci Research	ASDR-509869

Published: Jan 2020 - Pages : 86 - Publisher : TechSci Research - Report code : ASDR-509869

1.Sanofi S.A
2.Biocon Limited
3.Novo Nordisk A/S
4.Wockhardt Ltd
5.Eli Lily and Company
6.Geropharm LLC
7.Merck & Co.
8.Sandoz